Bill Gates is backing a company that has a novel way to treat disease
Exicure is building drugs out of RNA, or ribonucleic acid, that can silence mutated genes. Image: REUTERS/Joshua Roberts
Lydia Ramsey
Editorial Intern, Business Insider Science
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Fourth Industrial Revolution
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Global Agenda
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
Subscribe
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
